Warrants - Schedule of Warrant Activities (Details) - $ / shares |
6 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Jun. 30, 2025 |
|
| Schedule of Operating Leases [Abstract] | ||
| Ordinary Shares Number Outstanding, Ending | 14,907,000 | 14,907,000 |
| Weighted Average Exercise Price, Ending | $ 0.55 | $ 0.55 |
| Contractual Life in Years, Ending | 2 years | 1 year 6 months |
| Ordinary Shares Number Outstanding, Exercisable | 14,907,000 | |
| Weighted Average Exercise Price, Exercisable | $ 0.55 | |
| Contractual Life in Years, Exercisable | 1 year 6 months | |
| Ordinary Shares Number Outstanding, Granted | ||
| Weighted Average Exercise Price, Granted | ||
| Ordinary Shares Number Outstanding, Exercises | ||
| Weighted Average Exercise Price, Exercises | ||
| Ordinary Shares Number Outstanding, Expired | ||
| Weighted Average Exercise Price, Expired |
| X | ||||||||||
- Definition Share based compensation contractual term exercisable. . No definition available.
|
| X | ||||||||||
- Definition Ordinary shares number outstanding, exercisable. No definition available.
|
| X | ||||||||||
- Definition Share based compensation contractual term. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, exercisable. . No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, exercises. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, granted. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|